.jpg?format=webp&width=780)
The article discusses the use of weekly cisplatin chemotherapy with radiotherapy compared to 3-weekly cisplatin chemotherapy with radiotherapy in treating locoregionally advanced head and neck cancer. The authors conducted a literature review and found evidence supporting the noninferiority of weekly cisplatin chemotherapy in both adjuvant and definitive settings. However, there is a lack of superiority trials in the existing literature. The article highlights the need for further research to conclusively determine the efficacy of weekly cisplatin chemotherapy in treating locoregionally advanced head and neck cancer.
Like
Save
Share